• Sign In
  1. Targeted MS Runs

Set2_HL_Carolinas_sem pep ACAN_ncomm_2018-03-26_16-12-59.sky.zip

PaesLeme - SRM Saliva

Document Summary

 
 
7 proteins, 22 peptides, 36 precursors, 108 transitions  -  119 replicates  -  Skyline (64-bit) 4.1.0.11796

Peptide Map

 
16.6  1347.65sp|Q92597|NDRG1_HUMAN328-341 
(R)TASGSSVTSLDGTR(S)
 4,687,319
17.2  1337.64sp|Q92597|NDRG1_HUMAN328-341 
(R)TASGSSVTSLDGTR(S)
 0,530
17.7  900.55iRT Pierce  
DIPVPKPK
 344,611,936
18.3  843.46iRT Pierce  
IGDYAGIK
 2,337,779,200
20.0  1389.65iRT Pierce  
TASEFDSAIAQDK
 1,303,212,928
20.4  1389.65iRT Pierce  
TASEFDSAIAQDK
 518,457,568
20.9  1288.68sp|P12109|CO6A1_HUMAN200-210 
(R)LSIIATDHTYR(R)
 1,064,580
20.9  1298.69sp|P12109|CO6A1_HUMAN200-210 
(R)LSIIATDHTYR(R)
 10,663,741,440
21.3  1171.59iRT Pierce  
SAAGAFGPELSR
 9,280,225,280
21.8  1171.59iRT Pierce  
SAAGAFGPELSR
 6,287,706,624
22.2  1206.65sp|P09960|LKHA4_HUMAN155-165 
(K)LTYTAEVSVPK(E)
 11,759,430
22.2  1214.66sp|P09960|LKHA4_HUMAN155-165 
(K)LTYTAEVSVPK(E)
 8,163,365,888
22.8  1421.71sp|P04080|CYTB_HUMAN57-68 
(K)VHVGDEDFVHLR(V)
 316,283,328
22.8  1431.71sp|P04080|CYTB_HUMAN57-68 
(K)VHVGDEDFVHLR(V)
 376,573,376
22.9  1545.78iRT Pierce  
ELGQSGVDTYLQTK
 1,741,661,312
23.2  1451.80sp|P06756|ITAV_HUMAN339-351 
(K)LQEVGQVSVSLQR(A)
 994,522,176
23.3  1441.79sp|P06756|ITAV_HUMAN339-351 
(K)LQEVGQVSVSLQR(A)
 21,272,498
23.3  1545.78iRT Pierce  
ELGQSGVDTYLQTK
 682,357,312
25.0  1325.70sp|P04080|CYTB_HUMAN45-56 
(K)SQVVAGTNYFIK(V)
 211,938,352
25.0  1333.71sp|P04080|CYTB_HUMAN45-56 
(K)SQVVAGTNYFIK(V)
 174,459,888
25.3  923.40sp|P04080|CYTB_HUMAN92-98 
(K)HDELTYF(-)
 32,767,906
25.3  930.42sp|P04080|CYTB_HUMAN92-98 
(K)HDELTYF(-)
 1,528,883,328
26.0  1756.81sp|P12109|CO6A1_HUMAN991-1005 
(K)TAEYDVAYGESHLFR(V)
 4,029,569
26.0  1766.81sp|P12109|CO6A1_HUMAN991-1005 
(K)TAEYDVAYGESHLFR(V)
 7,890,411,520
26.5  1114.64iRT Pierce  
GLILVGGYGTR
 23,045,392,384
26.5  1488.77iRT Pierce  
SFANQPLEVVYSK
 3,499,463,936
26.5  1969.02sp|P02144|MYG_HUMAN104-119 
(K)YLEFISECIIQVLQSK(H)
Carbamidomethyl (C) @ C1114,049,007
26.5  1977.04sp|P02144|MYG_HUMAN104-119 
(K)YLEFISECIIQVLQSK(H)
Carbamidomethyl (C) @ C11180,269,440
26.7  1114.64iRT Pierce  
GLILVGGYGTR
 16,221,598,720
26.9  1488.77iRT Pierce  
SFANQPLEVVYSK
 3,122,160,384
26.9  1600.81iRT Pierce  
GILFVGSGVSGGEEGAR
 2,484,103,936
26.9  1841.94sp|Q92597|NDRG1_HUMAN4-19 
(R)EMQDVDLAEVKPLVEK(G)
 5,385,875
26.9  1849.96sp|Q92597|NDRG1_HUMAN4-19 
(R)EMQDVDLAEVKPLVEK(G)
 3,557,000,192
27.2  1600.81iRT Pierce  
GILFVGSGVSGGEEGAR
 1,541,399,680
28.7  1349.77sp|P12109|CO6A1_HUMAN136-148 
(K)GLEQLLVGGSHLK(E)
 41,249,088
28.7  1357.78sp|P12109|CO6A1_HUMAN136-148 
(K)GLEQLLVGGSHLK(E)
 26,205,292,544
29.3  995.59iRT Pierce  
LTILEELR
 11,477,690,368
30.8  1144.59iRT Pierce  
NGFILDGFPR
 14,142,403,584
31.0  1965.94sp|P00558|PGK1_HUMAN247-264 
(K)VLNNMEIGTSLFDEEGAK(I)
 5,735,614
31.0  1973.95sp|P00558|PGK1_HUMAN247-264 
(K)VLNNMEIGTSLFDEEGAK(I)
 1,828,371,456
31.2  1144.59iRT Pierce  
NGFILDGFPR
 6,907,229,184
32.0  1357.82sp|P02144|MYG_HUMAN65-78 
(K)HGATVLTALGGILK(K)
 6,821,379,584
32.1  1349.80sp|P02144|MYG_HUMAN65-78 
(K)HGATVLTALGGILK(K)
 5,910,444
32.2  1997.03sp|P06756|ITAV_HUMAN410-428 
(R)STGLNAVPSQILEGQWAAR(S)
 2,144,110
32.2  2007.04sp|P06756|ITAV_HUMAN410-428 
(R)STGLNAVPSQILEGQWAAR(S)
 8,796,682,240
32.3  1103.63sp|P00558|PGK1_HUMAN407-417 
(K)VLPGVDALSNI(-)
 39,734,702,080
32.4  1096.61sp|P00558|PGK1_HUMAN407-417 
(K)VLPGVDALSNI(-)
 189,761,712
32.9  2009.02sp|P09960|LKHA4_HUMAN494-510 
(K)DLSSHQLNEFLAQTLQR(A)
 13,155,801,088
33.1  1999.01sp|P09960|LKHA4_HUMAN494-510 
(K)DLSSHQLNEFLAQTLQR(A)
 5,605,260
36.1  1572.88sp|P06756|ITAV_HUMAN647-660 
(K)IYIGDDNPLTLIVK(A)
 11,138,411
36.1  1580.89sp|P06756|ITAV_HUMAN647-660 
(K)IYIGDDNPLTLIVK(A)
 134,819,760